Results 91 to 100 of about 4,351,429 (251)

Lysis-buffer-treated versus intact plaques.

open access: yes, 2019
H&E staining of s- and v-plaques on shows elimination of plaque surface cells (arrows) after lysis-buffer treatment.
Zhanna K. Nazarkina (6883388)   +9 more
core   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Calculation of the transmission peak at the band gap of one-dimensional photonic crystal with an active layer

open access: yesУчёные записки Казанского университета: Серия Физико-математические науки, 2018
Tamm plasmons (TP) attract interest due to their applications in a new type of lasers and high sensitivity sensors. Hybrid plasmonic-photonic crystals allow direct excitation of TP without prisms and gratings.
A.V. Koryukin
doaj  

The riparian zone quality index: a tool for monitoring environmental regulations and raising awareness

open access: yesVertigO
In Quebec, due to climate change, the provincial government established a Policy for the Protection of Shorelines, Littoral Zones, and Floodplains in 1987.
Richard Massicotte
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Buffer-compositions for HP1542 low spin down assay.

open access: yes, 2019
Buffer-compositions for HP1542 low spin down assay.
Barbara Waidner (256992)   +5 more
core   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Buffer Block Planning for Interconnect-Driven Floorplanning

open access: yes, 2008
This paper studies buffer block planning for interconnect-driven floorplanning in deep submicron designs. We first introduce the concept of feasible region (FR) for buffer insertion, and derive closed-form formula for FR.
Jason Cong Tianming   +2 more
core  

Spatial mapping of optical constants and thickness variations in ITO films and SiO2 buffer layers

open access: yesOptical Materials: X
In this work, we present detailed spectroscopic ellipsometry (SE) measurements across thirty indium tin oxide In2O3–SnO2 (ITO) substrates, providing insights into variations in the complex refractive index N˜ for the same commercial ITO material.
I. Aulika   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy